Kozbor D, Roder J C
Eur J Immunol. 1984 Jan;14(1):23-7. doi: 10.1002/eji.1830140105.
Stimulation of peripheral blood lymphocyte (PBL) cultures from tetanus toxoid (TT)-immunized donor with Epstein-Barr virus (EBV) yielded cells with much higher frequencies of hybrid formation (36 X 10(-7) compared to unstimulated PBL or cells cultured with pokeweed mitogen or TT antigen. The proportion of hybridomas (approximately 1%) producing anti-TT antibody was similar in EBV- and TT-stimulated cultures. A marked increase in immunoglobulin secretion was observed after hybridization and preselection of EBV subcultures for high anti-TT production prior to fusion resulted in a fivefold increase in TT-specific hybridomas (p less than 0.001). Most (20/21) specific hybrids produced IgM anti-TT, whereas one (1/21) produced IgG anti-TT, possibly due to the immature stage of differentiation in EBV-stimulated parental cells. The ability to choose an antigen, immunize a human subject and expand the rare antigen-specific B cells from PBL, in vitro, with EBV, prior to fusion, should yield an increasing spectrum of human monoclonal antibodies for diagnostic, therapeutic or basic studies.
用爱泼斯坦-巴尔病毒(EBV)刺激来自破伤风类毒素(TT)免疫供体的外周血淋巴细胞(PBL)培养物,产生的细胞形成杂交体的频率要高得多(36×10⁻⁷),相比未刺激的PBL或用商陆有丝分裂原或TT抗原培养的细胞。在EBV刺激的培养物和TT刺激的培养物中,产生抗TT抗体的杂交瘤比例(约1%)相似。杂交后观察到免疫球蛋白分泌显著增加,在融合前对EBV亚培养物进行预筛选以获得高抗TT产量,导致TT特异性杂交瘤增加了五倍(p<0.001)。大多数(20/21)特异性杂交瘤产生IgM抗TT,而一个(1/21)产生IgG抗TT,这可能是由于EBV刺激的亲代细胞处于未成熟分化阶段。在融合前,选择一种抗原、免疫人类受试者并在体外利用EBV从PBL中扩增罕见的抗原特异性B细胞的能力,应该会产生越来越多的用于诊断、治疗或基础研究的人单克隆抗体。